Creating a database for patients with Thrombotic Thrombocytopenic Purpura
Construction of a Database for Thrombotic Thrombocytopenic Purpura
This study is creating a detailed database of information about patients with Thrombotic Thrombocytopenic Purpura to help better understand the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Soochow University Academic / other |
| Locations | 1 site (Suzhou, Jiangsu) |
| Trial ID | NCT05571774 on ClinicalTrials.gov |
What this trial studies
This observational study aims to construct a comprehensive database for patients diagnosed with Thrombotic Thrombocytopenic Purpura (TTP) by collecting detailed patient information through the Hitech case system and follow-up methods. The study will gather data on approximately 200 cases over a five-year period, focusing on patient demographics and clinical characteristics related to TTP. The data will be organized using Epidata software to facilitate analysis and improve understanding of the condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with severe ADAMTS13 deficiency, characterized by an activity level of less than 10%.
Not a fit: Patients who are unable or unwilling to cooperate with the study procedures will not benefit from this study.
Why it matters
Potential benefit: If successful, this database could enhance the understanding of TTP and improve patient management and treatment strategies.
How similar studies have performed: While similar observational studies have been conducted, this specific approach to constructing a TTP database is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Subjects diagnosed with severe ADAMTS13 deficiency, defined as ADAMTS13 activity \<10%, documented in the patient's medical history or at screening. Exclusion Criteria: \- The investigator considers the subject unable or unwilling to cooperate with the study procedures.
Where this trial is running
Suzhou, Jiangsu
- the first affiliated hospital of Soochow university — Suzhou, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Yue Han, Ph.D
- Email: hanyue@suda.edu.cn
- Phone: +86 18913091817
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.